ANI
An 84-year-old man from Haryana who become the first person in India to be administered the Covid drug cocktail was discharged on Wednesday.
The antibody cocktail came into limelight after it was administered to former US President Donald Trump when he tested positive for the virus last year.
Mohabbat Singh, who was under treatment for the last five days at Gurugram s Medanta Hospital was on Tuesday given the drug over a 30 minute intravenous supply.
The cocktail of two fast acting antibodies-Casirivimab and Imdevimab is seen as a cutting-edge treatment that will provide protection to Covid-19 patients with mild and moderate symptoms before their condition deteriorates and they require hospitalization.
Haryana Man Becomes First In India To Receive Covid-19 Cocktail Drug Once Administered To Trump swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Octogenarian discharged after monoclonal antibody therapy
By IANS |
0 Views
Covid vaccine.. Image Source: IANS News
Gurugram, May 27 : An 84-year-old Covid patient, Mohabbat Singh, became the first patient in India to receive monoclonal antibody therapy at the Medanta Hospital in Gurugram.
The patient with multiple comorbidities was discharged from the hospital on Wednesday, a day after he was administered the jab. We are glad to have access to monoclonal antibody therapy in India now. This fast and effective treatment for Covid-19 will save patients at highest risk from falling critically ill, getting hospitalised or possibly dying of complications from Covid-19. We look forward to serving our patients with this therapy and saving more lives, Naresh Trehan, Chairman and Managing Director, Medanta, said in a statement.
Gurugram (Haryana) [India], May 26 (ANI): An 84-year-old man from Haryana with multiple co-morbidities was discharged from Medanta hospital after getting the jap of monoclonal antibody cocktail. He has become the first person in India to be administered the COVID drug cocktail, which came into the limelight after it was administered to former US President Donald Trump when he tested positive for the virus last year.